Your Search Results

Coronary access following TAVI

23 Nov 2021 – From PCR London Valves 2021

Using the anatomy and imaging section and simulators, our experts dissect the case of a typical TAVI patient, an 81-year-old male, former smoker, with hypertension, dyslipidemia, and gastric ulcer, symptomatic of effort dyspnea, with marked left ventricular hypertrophy and all the parameters of severe aortic stenosis,...

Transcatheter mitral edge-to-edge repair: procedural complications and lifetime management

23 Nov 2021 – From PCR London Valves 2021

This PCR London Valves 2021 session presents different kinds of complications in mitral procedures based on clinical cases: discuss the case of an 82-year-old male patient with symptomatic severe ischemic secondary mitral regurgitation, coronary artery disease, diabetes, and chronic kidney disease, among others!

Transcatheter mitral edge-to-edge repair: procedural complications and lifetime management

Transcatheter tricuspid valve interventions: the future

23 Nov 2021 – From PCR London Valves 2021

In this PCR London Valves 2021 session, observe the case of an 84-year-old, not overweight, quite active, female patient with a past history of restrictive cardiomyopathy and permanent atrial fibrillation, who presented with worsening dyspnea and obvious clinical signs of right ventricular heart failure, and discuss the...

Transcatheter tricuspid valve interventions: the future

Commissural alignment for TAVI

23 Nov 2021 – From PCR London Valves 2021

In this PCR London Valves 2021 session shot in the simulation lab, learn tips and tricks for achieving commissural alignment, review the strategy for improving TAVR outcomes, and discuss how to get the right imaging, the right tools, and the right patients.

Closing Ceremony

23 Nov 2021 – From PCR London Valves 2021

Looking back on some of the key moments of the PCR London Valves 2021, it is clear that we witnessed cutting-edge procedures in all three valves, pushed the guidelines to the limits and beyond, saw the future of valve procedures with a new TAVI device implanted, live-implanted...

The impact of the first transcatheter heart valve on the lifetime management of patients with aortic stenosis

18 May 2022 – From EUROPCR 2022

This session from EuroPCR 2022 will help you understand how the first bioprosthetic aortic valve may affect long-term outcomes of patients with aortic stenosis. Learn how to optimise their lifetime management and how to refine procedural steps during TAVI.

The impact of the first transcatheter heart valve on the lifetime management of patients with aortic stenosis

TAVI procedure optimisation with the cusp overlap technique

27 Sep 2021 – From PCR Tokyo Valves 2021

In this session, the speakers present the advantages of the cusp overlap technique, providing a technical overview, and predicting that it will lead to best-in-class permanent pacemaker implantation rates, and will also have a great impact on paravalvular leak rates and other clinical endpoints. They further support their point by...

TAVI procedure optimisation with the cusp overlap technique

Addressing the challenges of small annuli patients with the Evolut Platform

27 Sep 2021 – From PCR Tokyo Valves 2021

Recognizing that Asian patients, especially women with aortic stenosis, are smaller and have smaller annuli than European ones, for instance, this session discusses the challenges of treating these patients, among them prosthesis patient mismatch, annulus rupture, coronary occlusion, or vascular complication. In addition, the speakers will draw...

Addressing the challenges of small annuli patients with the Evolut Platform

Introducing Navitor: a new TAVR solution with an active paravalvular leak-sealing technology

27 Sep 2021 – From PCR Tokyo Valves 2021

Watch this session to view the live case from Copenhagen of a 77-year-old woman with severe aortic valve stenosis NYHA III, to get a precise description of the features of the Navitor system and the Naviseal technology, a new solution for reducing risk of paravalvular leak,...